BREAST CANCER WITH BRAIN METASTASIS
Clinical trials for BREAST CANCER WITH BRAIN METASTASIS explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER WITH BRAIN METASTASIS trials appear
Sign up with your email to follow new studies for BREAST CANCER WITH BRAIN METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer patients with brain tumors: drug combo trial launches
Disease control Not yet recruitingThis study tests whether adding bevacizumab to trastuzumab deruxtecan (T-DXd) helps control HER2-low breast cancer that has spread to the brain. About 140 adults with this condition will receive either T-DXd alone or T-DXd plus bevacizumab. The goal is to see which approach delay…
Matched conditions: BREAST CANCER WITH BRAIN METASTASIS
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
New hope for breast cancer patients with brain tumors: drug duo enters trial
Disease control Not yet recruitingThis study tests whether adding neratinib to the standard drug trastuzumab deruxtecan works better for HER2-positive breast cancer that has spread to the brain. About 202 women aged 18-70 will be randomly assigned to get the combination or the standard drug alone. The main goal i…
Matched conditions: BREAST CANCER WITH BRAIN METASTASIS
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC